Any stock, in context
CONCORDBIO · Healthcare
Concord Biotech Ltd.
Observation · 15 Oct 2026
How these are readConcord Biotech closed at ₹1,353.3 on 15 Oct 2026, 6.8% above its 200-day average and 6.9% below its 50-day average: above the long line, below the short one. It sits 15.1% below its highest close of the past year, in the middle fifth of its one-year range. Over three months it rose 1.4%, against a median of −2.7% for its sector (146 stocks) and −5.1% for every stock observed.
- vs 200-day
- +6.8%
- the long line
- vs 50-day
- −6.9%
- the short line
- From 52w high
- −15.1%
- ₹987.0₹1,615.0
- 3 months
- +1.4%
- sector median −2.7% · 59 of 146
Nifty Smallcap 250 · Healthcare · EQ series · median traded value ₹15 crore a day. A description of where the price sits, not a view on the stock.
- 1D
- −2.08%
- 1W
- –
- 1M
- −8.13%
- 3M
- +1.39%
- YTD
- –
- 1Y
- −9.69%
Quotes come from Yahoo Finance through this site's server and are cached for fifteen minutes; when the provider fails, the stored close is shown and labelled. The observation is computed from the latest snapshot. For research and education only; not investment advice.